Pfizer Inc.
Tissue factor pathway inhibitor antibodies and uses thereof
Last updated:
Abstract:
The invention relates to antibodies, and antigen-binding fragments thereof, that specifically bind TFPI and inhibit an activity thereof. Such antibodies and fragments are useful for treating bleeding disorders and shortening clotting time.
Status:
Grant
Type:
Utility
Filling date:
17 Dec 2019
Issue date:
29 Dec 2020